Dr. Ospina is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 Fisher Rd
Mob-B, Ste 3
Berlin, VT 05602Phone+1 802-225-5400Fax+1 802-225-5401
Education & Training
University of Vermont Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1998
Mercy Catholic Medical CenterResidency, Internal Medicine, 1992 - 1995
Universidad de Panama Faculty of MedicineClass of 1987
Certifications & Licensure
VT State Medical License 1998 - 2024
PA State Medical License 1993 - 1995
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Clinical Trials
- Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer Start of enrollment: 2009 Sep 01
- Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain Start of enrollment: 2011 May 01
Publications & Presentations
PubMed
- 10 citationsReversible Epstein-Barr virus-negative lymphadenopathy and bone marrow involved by Hodgkin's lymphoma in a rheumatoid arthritis patient undergoing long-term treatment ...Annika M. Svensson, Erica R. Jacobson, David Ospina, Barbara H. Tindle
International Journal of Hematology. 2006-01-01 - 4 citationsPhase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung cancer.Steven M. Grunberg, Matthew C. Dugan, Marc S. Greenblatt, David J. Ospina, John W. Valentine
Cancer Investigation. 2005-01-01
Press Mentions
Eswar Tipirneni, MD, Joins UVM Health Network – Central Vermont Medical Center Cancer TeamDecember 29th, 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
